Pub Date : 2022-03-28eCollection Date: 2022-01-01DOI: 10.3389/jaws.2022.10356
A L A Bloemendaal
Intraoperative fascial traction (IFT) may obviate the use of a posterior component separation/transversus abdominis release (TAR). Robotic abdominal wall surgery leads to a reduction of morbidity in TAR compared to open surgery. The combination of minimally invasive (robotic) abdominal wall surgery with IFT may lead to a further reduction of surgical morbidity.
术中筋膜牵引(IFT)可避免使用后部分离/腹横肌松解术(TAR)。与开腹手术相比,机器人腹壁手术可降低 TAR 的发病率。微创(机器人)腹壁手术与 IFT 的结合可进一步降低手术发病率。
{"title":"Case Report: Intraoperative Fascial Traction in Robotic Abdominal Wall Surgery; An Early Experience.","authors":"A L A Bloemendaal","doi":"10.3389/jaws.2022.10356","DOIUrl":"10.3389/jaws.2022.10356","url":null,"abstract":"<p><p>Intraoperative fascial traction (IFT) may obviate the use of a posterior component separation/transversus abdominis release (TAR). Robotic abdominal wall surgery leads to a reduction of morbidity in TAR compared to open surgery. The combination of minimally invasive (robotic) abdominal wall surgery with IFT may lead to a further reduction of surgical morbidity.</p>","PeriodicalId":7590,"journal":{"name":"American Journal of Physiology","volume":"122 1","pages":"10356"},"PeriodicalIF":0.0,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86278001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-01Epub Date: 2019-11-19DOI: 10.1177/0271678X19889092
Yuying Zhang, Evan D Bander, Yurim Lee, Celia Muoser, Chris B Schaffer, Nozomi Nishimura
Vascular dysfunction is correlated to the incidence and severity of Alzheimer's disease. In a mouse model of Alzheimer's disease (APP/PS1) using in vivo, time-lapse, multiphoton microscopy, we found that occlusions of the microvasculature alter amyloid-beta (Aβ) plaques. We used several models of vascular injury that varied in severity. Femtosecond laser-induced occlusions in single capillaries generated a transient increase in small, cell-sized, Aβ deposits visualized with methoxy-X04, a label of fibrillar Aβ. After occlusions of penetrating arterioles, some plaques changed morphology, while others disappeared, and some new plaques appeared within a week after the lesion. Antibody labeling of Aβ revealed a transient increase in non-fibrillar Aβ one day after the occlusion that coincided with the disappearance of methoxy-X04-labeled plaques. Four days after the lesion, anti-Aβ labeling decreased and only remained in patches unlabeled by methoxy-X04 near microglia. Histology in two additional models, sparse embolic occlusions from intracarotid injections of beads and infarction from photothrombosis, demonstrated increased labeling intensity in plaques after injury. These results suggest that microvascular lesions can alter the deposition and clearance of Aβ and confirm that Aβ plaques are dynamic structures, complicating the interpretation of plaque burden as a marker of Alzheimer's disease progression.
{"title":"Microvessel occlusions alter amyloid-beta plaque morphology in a mouse model of Alzheimer's disease.","authors":"Yuying Zhang, Evan D Bander, Yurim Lee, Celia Muoser, Chris B Schaffer, Nozomi Nishimura","doi":"10.1177/0271678X19889092","DOIUrl":"10.1177/0271678X19889092","url":null,"abstract":"<p><p>Vascular dysfunction is correlated to the incidence and severity of Alzheimer's disease. In a mouse model of Alzheimer's disease (APP/PS1) using in vivo, time-lapse, multiphoton microscopy, we found that occlusions of the microvasculature alter amyloid-beta (Aβ) plaques. We used several models of vascular injury that varied in severity. Femtosecond laser-induced occlusions in single capillaries generated a transient increase in small, cell-sized, Aβ deposits visualized with methoxy-X04, a label of fibrillar Aβ. After occlusions of penetrating arterioles, some plaques changed morphology, while others disappeared, and some new plaques appeared within a week after the lesion. Antibody labeling of Aβ revealed a transient increase in non-fibrillar Aβ one day after the occlusion that coincided with the disappearance of methoxy-X04-labeled plaques. Four days after the lesion, anti-Aβ labeling decreased and only remained in patches unlabeled by methoxy-X04 near microglia. Histology in two additional models, sparse embolic occlusions from intracarotid injections of beads and infarction from photothrombosis, demonstrated increased labeling intensity in plaques after injury. These results suggest that microvascular lesions can alter the deposition and clearance of Aβ and confirm that Aβ plaques are dynamic structures, complicating the interpretation of plaque burden as a marker of Alzheimer's disease progression.</p>","PeriodicalId":7590,"journal":{"name":"American Journal of Physiology","volume":"131 1","pages":"2115-2131"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86321145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01Epub Date: 2020-06-05DOI: 10.1007/s12467-020-0132-1
D Mul, H J Aanstoot, H J Veeze
{"title":"De virtuele diabeteskliniek in een stroomversnelling?","authors":"D Mul, H J Aanstoot, H J Veeze","doi":"10.1007/s12467-020-0132-1","DOIUrl":"10.1007/s12467-020-0132-1","url":null,"abstract":"","PeriodicalId":7590,"journal":{"name":"American Journal of Physiology","volume":"98 1","pages":"16-26"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305482/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86170691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-01Epub Date: 2019-09-26DOI: 10.1002/mp.13803
Sharath K Bhagavatula, Kunj Upadhyaya, Brendyn J Miller, Patrick Bursch, Alex Lammers, Michael J Cima, Stuart G Silverman, Oliver Jonas
<p><strong>Purpose: </strong>Recently developed implantable microdevices can perform multi-drug response assessment of cancer drugs in-vivo, with potential to develop highly optimized personalized cancer treatment strategies. However, minimally invasive/interventional image-guided methods of in-vivo microdevice implantation, securement, and retrieval are needed for broad clinical translation. Here we demonstrate proof-of-concept of an interventional microdevice implantation and retrieval method for personalized drug response assessment, using ex-vivo phantom, ex-vivo tissue, and in-vivo murine models.</p><p><strong>Methods: </strong>A method for minimally-invasive microdevice implantation and retrieval was developed, by which a custom-prototyped 6 mm retrievable microdevice can be implanted into a live tumor, deliver drugs into 10 discrete regions of adjacent tissue, and retrieved along with the adjacent drug-exposed tissue with a custom-prototyped retrieval needle device to allow in-vivo multi-drug response assessment. Computed tomography (CT) and ultrasound (US)-guided minimally invasive microdevice implantation and retrieval were tested in ex-vivo phantom and tissue models. Successful retrieval was defined as retrieval of the microdevice and adjacent core phantom/tissue sample containing at least 4/10 drug delivery sites. Subsequently, 10 implantation and retrieval trials in phantom models were performed using bi-axial and tri-axial retrieval needles; success rates were calculated and compared using a two-proportion z-test and the number of successfully retrieved drug release sites per microdevice was calculated and compared using a one-tailed independent t-test. Finally, five microdevices, each containing ten reservoirs preloaded with chemotherapy agent Doxorubicin, were implanted into mouse tumors in-vivo, secured for 24-h during drug release, and microdevice/tissue retrieval was performed under ultrasound guidance. Fluorescence microscopy of the retrieved tissue was used to confirm drug delivery and apoptosis staining assessed in-vivo tissue response; correlation of drug release and apoptosis staining were used to assess in-vivo drug efficacy.</p><p><strong>Results: </strong>Image-guided microdevice implantation and retrieval were successful in ex-vivo phantom and tissue models with both US and CT guidance. Bi-axial retrieval success rate was significantly higher than triaxial retrieval in ex-vivo phantom trials (90% vs 50%, z = 1.95, P = 0.026), and had nonsignificantly higher number of retrieved drug-release sites per microdevice (8.3 vs 7.0, t = 1.37, P = 0.097). Bi-axial retrieval was successful in all five in-vivo mouse tumor models, and allowed in-vivo drug response assessment at up to ten discrete drug delivery sites per microdevice. An average of 6.8/10 discrete tumor sites containing micro-doses of delivered drug were retrieved per in-vivo attempt (min 5, max 10, std 1.93). Tissue regions of drug delivery, as assessed with fluoresc
目的:最近开发的植入式微型装置可在体内对癌症药物进行多种药物反应评估,有望开发出高度优化的个性化癌症治疗策略。然而,体内微型装置的植入、固定和回收需要微创/介入图像引导方法,以实现广泛的临床转化。在此,我们利用体外模型、体外组织和体内小鼠模型,展示了用于个性化药物反应评估的介入性微装置植入和回收方法的概念验证:方法:开发了一种微创微型装置植入和取出方法,通过这种方法可将定制的 6 毫米可取式微装置植入活体肿瘤,向邻近组织的 10 个离散区域输送药物,并用定制的取针装置将邻近药物暴露组织一并取出,以进行体内多种药物反应评估。在体外模型和组织模型中测试了计算机断层扫描(CT)和超声波(US)引导下的微创微型装置植入和回收。成功取回的定义是取回微装置和至少包含 4/10 个给药点的邻近核心模型/组织样本。随后,使用双轴和三轴取回针在模型中进行了 10 次植入和取回试验;使用双比例 z 检验计算和比较成功率,使用单尾独立 t 检验计算和比较每个微器件成功取回的药物释放点数量。最后,将五个微装置(每个装置包含十个预装化疗药物多柔比星的储库)植入小鼠体内肿瘤,在药物释放期间固定24小时,并在超声引导下进行微装置/组织回收。取回组织的荧光显微镜用于确认药物输送,凋亡染色用于评估体内组织反应;药物释放和凋亡染色的相关性用于评估体内药物疗效:结果:在US和CT引导下,在体外模型和组织模型中成功进行了图像引导下的微型装置植入和取出。在体外模型试验中,双轴取回成功率明显高于三轴取回(90% vs 50%,z = 1.95,P = 0.026),每个微器件取回的药物释放点数量也明显高于三轴取回(8.3 vs 7.0,t = 1.37,P = 0.097)。双轴检索在所有五种体内小鼠肿瘤模型中都取得了成功,并可对每个微装置上多达十个离散给药点进行体内药物反应评估。每次体内尝试平均可在 6.8/10 个离散的肿瘤部位取回微剂量的给药剂量(最少 5 个,最多 10 个,标准差 1.93)。用荧光多柔比星药物信号评估的组织给药区域与所有体内模型的细胞凋亡染色区域相关,表明药物具有疗效。在植入、24 小时观察或取出过程中,未发现出血、微型装置移位或其他并发症:所展示的图像引导微创微器件植入和取出方法与常规门诊活检程序相似,无需手术,可在 CT 和/或 US 引导下在不同深度进行。这种方法有可能使体内个性化药物反应评估/预测的临床转化成为可能,其适用患者数量远远超过目前的水平。
{"title":"An interventional image-guided microdevice implantation and retrieval method for in-vivo drug response assessment.","authors":"Sharath K Bhagavatula, Kunj Upadhyaya, Brendyn J Miller, Patrick Bursch, Alex Lammers, Michael J Cima, Stuart G Silverman, Oliver Jonas","doi":"10.1002/mp.13803","DOIUrl":"10.1002/mp.13803","url":null,"abstract":"<p><strong>Purpose: </strong>Recently developed implantable microdevices can perform multi-drug response assessment of cancer drugs in-vivo, with potential to develop highly optimized personalized cancer treatment strategies. However, minimally invasive/interventional image-guided methods of in-vivo microdevice implantation, securement, and retrieval are needed for broad clinical translation. Here we demonstrate proof-of-concept of an interventional microdevice implantation and retrieval method for personalized drug response assessment, using ex-vivo phantom, ex-vivo tissue, and in-vivo murine models.</p><p><strong>Methods: </strong>A method for minimally-invasive microdevice implantation and retrieval was developed, by which a custom-prototyped 6 mm retrievable microdevice can be implanted into a live tumor, deliver drugs into 10 discrete regions of adjacent tissue, and retrieved along with the adjacent drug-exposed tissue with a custom-prototyped retrieval needle device to allow in-vivo multi-drug response assessment. Computed tomography (CT) and ultrasound (US)-guided minimally invasive microdevice implantation and retrieval were tested in ex-vivo phantom and tissue models. Successful retrieval was defined as retrieval of the microdevice and adjacent core phantom/tissue sample containing at least 4/10 drug delivery sites. Subsequently, 10 implantation and retrieval trials in phantom models were performed using bi-axial and tri-axial retrieval needles; success rates were calculated and compared using a two-proportion z-test and the number of successfully retrieved drug release sites per microdevice was calculated and compared using a one-tailed independent t-test. Finally, five microdevices, each containing ten reservoirs preloaded with chemotherapy agent Doxorubicin, were implanted into mouse tumors in-vivo, secured for 24-h during drug release, and microdevice/tissue retrieval was performed under ultrasound guidance. Fluorescence microscopy of the retrieved tissue was used to confirm drug delivery and apoptosis staining assessed in-vivo tissue response; correlation of drug release and apoptosis staining were used to assess in-vivo drug efficacy.</p><p><strong>Results: </strong>Image-guided microdevice implantation and retrieval were successful in ex-vivo phantom and tissue models with both US and CT guidance. Bi-axial retrieval success rate was significantly higher than triaxial retrieval in ex-vivo phantom trials (90% vs 50%, z = 1.95, P = 0.026), and had nonsignificantly higher number of retrieved drug-release sites per microdevice (8.3 vs 7.0, t = 1.37, P = 0.097). Bi-axial retrieval was successful in all five in-vivo mouse tumor models, and allowed in-vivo drug response assessment at up to ten discrete drug delivery sites per microdevice. An average of 6.8/10 discrete tumor sites containing micro-doses of delivered drug were retrieved per in-vivo attempt (min 5, max 10, std 1.93). Tissue regions of drug delivery, as assessed with fluoresc","PeriodicalId":7590,"journal":{"name":"American Journal of Physiology","volume":"88 1","pages":"5134-5143"},"PeriodicalIF":3.2,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86870415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-20DOI: 10.3390/medicina55100610
Dzintars Ozols, Marisa Maija Butnere, Aigars Petersons
Background and objectives: Congenital thumb hypoplasia is a rare deformity of upper extremity. The incidence for thumb hypoplasia grade II-V is 1:10,000 newborns per year in Latvia. A technique for extensor indicis proprius (EIP) tendon transfer with subperiosteal fixation was developed and used for thumb hypoplasia grades II and IIIa. Pollicization or second-toe-to-hand transplantation with metatarsophalangeal (MTP) joint arthrodesis was used for the reconstruction of hypoplasia grade IIIb-V. The aim of this retrospective cohort study is to evaluate the outcomes for reconstruction techniques used in one surgical center during a ten-year period by one surgeon to evaluate functional and aesthetical outcomes for new techniques.
Materials and methods: In total, 21 patients were operated on during 2007-2017, and 18 of these patients were involved in this study. Long-term follow-up was completed to evaluate the functions and aesthetics of the hands.
Results: disabilities of the arm, shoulder and hand (DASH) was 9.35 (8-10.7) for the second-toe-to-hand with MTP joint arthrodesis transplantation method for pollicization method 19.8 (6-26.7), and for the EIP tendon transposition, 14.54 (0.9-56.3).
Conclusions: The postoperative functional parameters of congenital hand hypoplasia patients, regardless of the surgical method, are worse than the functional results of healthy patients. The use of the second-toe-to-hand with MTP joint arthrodesis transplantation method provides patients with congenital hand IIIb-V hypoplasia a stable and functional first finger formation. The functional results are comparable to the clinical results of the pollicization method while ensuring the creation of a five-digit hand.
{"title":"Methods for Congenital Thumb Hypoplasia Reconstruction. A Review of the Outcomes for Ten Years of Surgical Treatment.","authors":"Dzintars Ozols, Marisa Maija Butnere, Aigars Petersons","doi":"10.3390/medicina55100610","DOIUrl":"10.3390/medicina55100610","url":null,"abstract":"<p><strong>Background and objectives: </strong>Congenital thumb hypoplasia is a rare deformity of upper extremity. The incidence for thumb hypoplasia grade II-V is 1:10,000 newborns per year in Latvia. A technique for extensor indicis proprius (EIP) tendon transfer with subperiosteal fixation was developed and used for thumb hypoplasia grades II and IIIa. Pollicization or second-toe-to-hand transplantation with metatarsophalangeal (MTP) joint arthrodesis was used for the reconstruction of hypoplasia grade IIIb-V. The aim of this retrospective cohort study is to evaluate the outcomes for reconstruction techniques used in one surgical center during a ten-year period by one surgeon to evaluate functional and aesthetical outcomes for new techniques.</p><p><strong>Materials and methods: </strong>In total, 21 patients were operated on during 2007-2017, and 18 of these patients were involved in this study. Long-term follow-up was completed to evaluate the functions and aesthetics of the hands.</p><p><strong>Results: </strong>disabilities of the arm, shoulder and hand (DASH) was 9.35 (8-10.7) for the second-toe-to-hand with MTP joint arthrodesis transplantation method for pollicization method 19.8 (6-26.7), and for the EIP tendon transposition, 14.54 (0.9-56.3).</p><p><strong>Conclusions: </strong>The postoperative functional parameters of congenital hand hypoplasia patients, regardless of the surgical method, are worse than the functional results of healthy patients<b>.</b> The use of the second-toe-to-hand with MTP joint arthrodesis transplantation method provides patients with congenital hand IIIb-V hypoplasia a stable and functional first finger formation. The functional results are comparable to the clinical results of the pollicization method while ensuring the creation of a five-digit hand.</p>","PeriodicalId":7590,"journal":{"name":"American Journal of Physiology","volume":"28 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2019-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86700837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-05-16eCollection Date: 2019-05-01DOI: 10.1097/GOX.0000000000002228
Kim H Lim, Tinte Itinteang, Paul F Davis, Swee T Tan
Keloid disorder (KD) is a fibroproliferative condition caused by dysregulated wound healing following wounding of the skin. The pathogenesis of KD has not been fully elucidated and current treatment is unsatisfactory. There is increasing evidence of the role of stem cells in KD. This review discusses the role of embryonic stem (ESC)-like cells and mesenchymal stem cells in the pathogenesis of KD. It is proposed that dysfunction of the ESC-like population localized to the endothelium of the microvessels and perivascular cells within the keloid-associated lymphoid tissues may give rise to the aberrant fibroblasts and myofibroblasts via a mesenchymal stem cell intermediate in keloid lesions, by undergoing an endothelial-to-mesenchymal transition. We also discuss the role of the renin-angiotensin system (RAS), the immune system, and the inflammatory response, on stem cell proliferation and differentiation. The understanding of the precise roles of these stem cells and interplay of the associated regulatory pathways could lead to the development of targeted therapy for this enigmatic and challenging condition. The demonstration of the expression of components of the RAS and cathepsins B, D, and G that constitute bypass loops of the RAS, by the ESC-like population, suggests that the primitive population may be a therapeutic target by modulation of the RAS, using existing medications.
{"title":"Stem Cells in Keloid Lesions: A Review.","authors":"Kim H Lim, Tinte Itinteang, Paul F Davis, Swee T Tan","doi":"10.1097/GOX.0000000000002228","DOIUrl":"10.1097/GOX.0000000000002228","url":null,"abstract":"<p><p>Keloid disorder (KD) is a fibroproliferative condition caused by dysregulated wound healing following wounding of the skin. The pathogenesis of KD has not been fully elucidated and current treatment is unsatisfactory. There is increasing evidence of the role of stem cells in KD. This review discusses the role of embryonic stem (ESC)-like cells and mesenchymal stem cells in the pathogenesis of KD. It is proposed that dysfunction of the ESC-like population localized to the endothelium of the microvessels and perivascular cells within the keloid-associated lymphoid tissues may give rise to the aberrant fibroblasts and myofibroblasts via a mesenchymal stem cell intermediate in keloid lesions, by undergoing an endothelial-to-mesenchymal transition. We also discuss the role of the renin-angiotensin system (RAS), the immune system, and the inflammatory response, on stem cell proliferation and differentiation. The understanding of the precise roles of these stem cells and interplay of the associated regulatory pathways could lead to the development of targeted therapy for this enigmatic and challenging condition. The demonstration of the expression of components of the RAS and cathepsins B, D, and G that constitute bypass loops of the RAS, by the ESC-like population, suggests that the primitive population may be a therapeutic target by modulation of the RAS, using existing medications.</p>","PeriodicalId":7590,"journal":{"name":"American Journal of Physiology","volume":"97 1","pages":"e2228"},"PeriodicalIF":1.5,"publicationDate":"2019-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86169783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The human gut microbiome has profound influences on the host's health largely through its interference with various intestinal functions. As recent studies have suggested diversity in the human gut microbiome among human populations, it will be interesting to analyse how gut microbiome is correlated with geographical, cultural, and traditional differences. The Japanese people are known to have several characteristic features such as eating a variety of traditional foods and exhibiting a low BMI and long life span. In this study, we analysed gut microbiomes of the Japanese by comparing the metagenomic data obtained from 106 Japanese individuals with those from 11 other nations. We found that the composition of the Japanese gut microbiome showed more abundant in the phylum Actinobacteria, in particular in the genus Bifidobacterium, than other nations. Regarding the microbial functions, those of carbohydrate metabolism were overrepresented with a concurrent decrease in those for replication and repair, and cell motility. The remarkable low prevalence of genes for methanogenesis with a significant depletion of the archaeon Methanobrevibacter smithii and enrichment of acetogenesis genes in the Japanese gut microbiome compared with others suggested a difference in the hydrogen metabolism pathway in the gut between them. It thus seems that the gut microbiome of the Japanese is considerably different from those of other populations, which cannot be simply explained by diet alone. We postulate possible existence of hitherto unknown factors contributing to the population-level diversity in human gut microbiomes.
{"title":"The gut microbiome of healthy Japanese and its microbial and functional uniqueness.","authors":"Suguru Nishijima, Wataru Suda, Kenshiro Oshima, Seok-Won Kim, Yuu Hirose, Hidetoshi Morita, Masahira Hattori","doi":"10.1093/dnares/dsw002","DOIUrl":"10.1093/dnares/dsw002","url":null,"abstract":"<p><p>The human gut microbiome has profound influences on the host's health largely through its interference with various intestinal functions. As recent studies have suggested diversity in the human gut microbiome among human populations, it will be interesting to analyse how gut microbiome is correlated with geographical, cultural, and traditional differences. The Japanese people are known to have several characteristic features such as eating a variety of traditional foods and exhibiting a low BMI and long life span. In this study, we analysed gut microbiomes of the Japanese by comparing the metagenomic data obtained from 106 Japanese individuals with those from 11 other nations. We found that the composition of the Japanese gut microbiome showed more abundant in the phylum Actinobacteria, in particular in the genus Bifidobacterium, than other nations. Regarding the microbial functions, those of carbohydrate metabolism were overrepresented with a concurrent decrease in those for replication and repair, and cell motility. The remarkable low prevalence of genes for methanogenesis with a significant depletion of the archaeon Methanobrevibacter smithii and enrichment of acetogenesis genes in the Japanese gut microbiome compared with others suggested a difference in the hydrogen metabolism pathway in the gut between them. It thus seems that the gut microbiome of the Japanese is considerably different from those of other populations, which cannot be simply explained by diet alone. We postulate possible existence of hitherto unknown factors contributing to the population-level diversity in human gut microbiomes.</p>","PeriodicalId":7590,"journal":{"name":"American Journal of Physiology","volume":"88 1","pages":"125-33"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86867911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hospital overcrowding.","authors":"S K Mishra","doi":"10.1136/ewjm.174.3.170","DOIUrl":"10.1136/ewjm.174.3.170","url":null,"abstract":"","PeriodicalId":7590,"journal":{"name":"American Journal of Physiology","volume":"34 1","pages":"170"},"PeriodicalIF":0.0,"publicationDate":"2001-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1071303/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86713134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1999-12-01DOI: 10.1152/ajpregu.1999.277.6.R1605
Y Wang, K R Olson, M P Smith, M J Russell, J M Conlon
Endothelin (ET) from a nontetrapod species has never been characterized, either structurally or biologically. A single molecular form of trout ET with 21-amino-acid residues was isolated in pure form from an extract of the kidney of the steelhead trout, Oncorhynchus mykiss and its primary structure established as Cys-Ser-Cys-Ala-Thr-Phe-Leu-Asp-Lys-Glu10-Cys-Val-Tyr-Phe-Cys-His- L eu-Asp-Ile-Ile20-Trp. This amino acid sequence shows only three substitutions (Ala4-->Ser, Thr5-->Ser, and Phe6-->Trp) compared with human ET-2, demonstrating that the structure of the peptide has been well conserved during evolution and that the pathway of posttranslational processing of preproendothelin in the trout is probably similar to that in mammals. Synthetic trout ET produced concentration-dependent constrictions of isolated rings of vascular tissue from trout efferent branchial artery (EBA; pD2 = 7. 90 +/- 0.06, n = 5), caeliacomesenteric artery (pD2 = 8.03 +/- 0. 04, n = 4), anterior cardinal vein (ACV; pD2 = 8.57 +/- 0.25, n = 4), and rat abdominal aorta (AO; pD2 = 8.86 +/- 0.08, n = 7). Trout and rat vessels were more sensitive to mammalian ET-1 than to trout ET (pD(2) for human ET-1 in: EBA = 9.12 +/- 0.14; ACV = 9.90 +/- 0.15; AO = 8.86 +/- 0.08), but there was no significant difference in the maximum tension produced by either peptide in these vessels.
非四足动物的内皮素(ET)从未在结构上或生物学上被表征过。从钢头鳟鱼(Oncorhynchus mykiss)的肾脏提取液中分离到具有21个氨基酸残基的单分子形式的鳟鱼ET,其主要结构为cys - ser - cys - ala - thr - ph - leu - asp - lys - hys - glu10 - cys - val - tyr - ph - cys - his -L eu-Asp-Ile-Ile20-Trp。与人类ET-2相比,该氨基酸序列仅显示了3个取代(Ala4- >Ser, Thr5- >Ser和Phe6- >Trp),表明该肽的结构在进化过程中得到了很好的保守,并且在鳟鱼中pre - pro内皮素的翻译后加工途径可能与哺乳动物相似。合成鳟鱼ET产生浓度依赖性的离体血管组织环收缩,来自鳟鱼出鳃动脉(EBA;pD2 = 7。90 +/- 0.06, n = 5),腹腔肠系膜动脉(pD2 = 8.03 +/- 0。4例,n = 4),前主静脉(ACV;pD2 = 8.57 +/- 0.25, n = 4),大鼠腹主动脉(AO;pD2 = 8.86 +/- 0.08, n = 7)。鳟鱼和大鼠血管对哺乳动物ET-1的敏感性高于鳟鱼(人类ET-1的pD(2): EBA = 9.12 +/- 0.14;Acv = 9.90 +/- 0.15;AO = 8.86 +/- 0.08),但两种肽在这些血管中产生的最大张力无显著差异。
{"title":"Purification, structural characterization, and myotropic activity of endothelin from trout, Oncorhynchus mykiss.","authors":"Y Wang, K R Olson, M P Smith, M J Russell, J M Conlon","doi":"10.1152/ajpregu.1999.277.6.R1605","DOIUrl":"https://doi.org/10.1152/ajpregu.1999.277.6.R1605","url":null,"abstract":"<p><p>Endothelin (ET) from a nontetrapod species has never been characterized, either structurally or biologically. A single molecular form of trout ET with 21-amino-acid residues was isolated in pure form from an extract of the kidney of the steelhead trout, Oncorhynchus mykiss and its primary structure established as Cys-Ser-Cys-Ala-Thr-Phe-Leu-Asp-Lys-Glu10-Cys-Val-Tyr-Phe-Cys-His- L eu-Asp-Ile-Ile20-Trp. This amino acid sequence shows only three substitutions (Ala4-->Ser, Thr5-->Ser, and Phe6-->Trp) compared with human ET-2, demonstrating that the structure of the peptide has been well conserved during evolution and that the pathway of posttranslational processing of preproendothelin in the trout is probably similar to that in mammals. Synthetic trout ET produced concentration-dependent constrictions of isolated rings of vascular tissue from trout efferent branchial artery (EBA; pD2 = 7. 90 +/- 0.06, n = 5), caeliacomesenteric artery (pD2 = 8.03 +/- 0. 04, n = 4), anterior cardinal vein (ACV; pD2 = 8.57 +/- 0.25, n = 4), and rat abdominal aorta (AO; pD2 = 8.86 +/- 0.08, n = 7). Trout and rat vessels were more sensitive to mammalian ET-1 than to trout ET (pD(2) for human ET-1 in: EBA = 9.12 +/- 0.14; ACV = 9.90 +/- 0.15; AO = 8.86 +/- 0.08), but there was no significant difference in the maximum tension produced by either peptide in these vessels.</p>","PeriodicalId":7590,"journal":{"name":"American Journal of Physiology","volume":"277 6","pages":"R1605-11"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1152/ajpregu.1999.277.6.R1605","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21458567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1999-12-01DOI: 10.1152/ajpcell.1999.277.6.C1100
H Shumaker, M Soleimani
The purpose of the current experiments was 1) to assess basolateral Na(+)-K(+)-2Cl(-) cotransporter (NKCC1) expression and 2) to ascertain the role of cystic fibrosis transmembrane conductance regulator (CFTR) in the regulation of this transporter in a prototypical pancreatic duct epithelial cell line. Previously validated human pancreatic duct cell lines (CFPAC-1), which exhibit physiological features prototypical of cystic fibrosis, and normal pancreatic duct epithelia (stable recombinant CFTR-bearing CFPAC-1 cells, termed CFPAC-WT) were grown to confluence before molecular and functional studies. High-stringency Northern blot hybridization, utilizing specific cDNA probes, confirmed that NKCC1 was expressed in both cell lines and its mRNA levels were twofold higher in CFPAC-WT cells than in CFPAC-1 cells (P < 0.01, n = 3). Na(+)-K(+)-2Cl(-) cotransporter activity, assayed as the bumetanide-sensitive, Na(+)- and Cl(-)-dependent NH(+)(4) entry into the cell (with NH(+)(4) acting as a substitute for K(+)), increased by approximately 115% in CFPAC-WT cells compared with CFPAC-1 cells (P < 0.01, n = 6). Reducing the intracellular Cl(-) by incubating the cells in a Cl(-)-free medium increased Na(+)-K(+)-2Cl(-) cotransporter activity by twofold (P < 0.01, n = 4) only in CFPAC-WT cells. We concluded that NKCC1 is expressed in pancreatic duct cells and mediates the entry of Cl(-). NKCC1 activity is enhanced in the presence of an inward Cl(-) gradient. The results further indicate that the presence of functional CFTR enhances the expression of NKCC1. We speculate that CFTR regulates this process in a Cl(-)-dependent manner.
本实验的目的是:1)评估基底外侧Na(+)- k (+)- 2cl(-)共转运体(NKCC1)的表达;2)确定囊性纤维化跨膜传导调节剂(CFTR)在典型胰管上皮细胞系中对该转运体的调控作用。先前验证的人胰管细胞系(CFPAC-1)表现出囊性纤维化的生理特征原型,与正常胰管上皮(稳定的重组CFPAC-1细胞,称为CFPAC-WT)生长融合,然后进行分子和功能研究。利用特异性cDNA探针进行高强度Northern杂交,证实NKCC1在两种细胞系中均有表达,其mRNA水平在CFPAC-WT细胞中比在CFPAC-1细胞中高两倍(P < 0.01, n = 3)。作为布美他尼敏感、Na(+)-和Cl(-)依赖的NH(+)(4)进入细胞(NH(+)(4)替代K(+)),检测了Na(+)-K(+)- 2cl(-)共转运体活性。与CFPAC-1细胞相比,CFPAC-WT细胞中Na(+)- k (+)- 2cl(-)共转运体活性增加了约115% (P < 0.01, n = 6)。仅在CFPAC-WT细胞中,通过在无Cl(-)培养基中培养细胞来降低细胞内Cl(-),使Na(+)- k (+)- 2cl(-)共转运体活性增加了两倍(P < 0.01, n = 4)。我们得出结论,NKCC1在胰管细胞中表达并介导Cl(-)的进入。NKCC1活性在Cl(-)向内梯度的存在下增强。结果进一步表明,功能性CFTR的存在增强了NKCC1的表达。我们推测CFTR以Cl(-)依赖的方式调节这一过程。
{"title":"CFTR upregulates the expression of the basolateral Na(+)-K(+)-2Cl(-) cotransporter in cultured pancreatic duct cells.","authors":"H Shumaker, M Soleimani","doi":"10.1152/ajpcell.1999.277.6.C1100","DOIUrl":"https://doi.org/10.1152/ajpcell.1999.277.6.C1100","url":null,"abstract":"<p><p>The purpose of the current experiments was 1) to assess basolateral Na(+)-K(+)-2Cl(-) cotransporter (NKCC1) expression and 2) to ascertain the role of cystic fibrosis transmembrane conductance regulator (CFTR) in the regulation of this transporter in a prototypical pancreatic duct epithelial cell line. Previously validated human pancreatic duct cell lines (CFPAC-1), which exhibit physiological features prototypical of cystic fibrosis, and normal pancreatic duct epithelia (stable recombinant CFTR-bearing CFPAC-1 cells, termed CFPAC-WT) were grown to confluence before molecular and functional studies. High-stringency Northern blot hybridization, utilizing specific cDNA probes, confirmed that NKCC1 was expressed in both cell lines and its mRNA levels were twofold higher in CFPAC-WT cells than in CFPAC-1 cells (P < 0.01, n = 3). Na(+)-K(+)-2Cl(-) cotransporter activity, assayed as the bumetanide-sensitive, Na(+)- and Cl(-)-dependent NH(+)(4) entry into the cell (with NH(+)(4) acting as a substitute for K(+)), increased by approximately 115% in CFPAC-WT cells compared with CFPAC-1 cells (P < 0.01, n = 6). Reducing the intracellular Cl(-) by incubating the cells in a Cl(-)-free medium increased Na(+)-K(+)-2Cl(-) cotransporter activity by twofold (P < 0.01, n = 4) only in CFPAC-WT cells. We concluded that NKCC1 is expressed in pancreatic duct cells and mediates the entry of Cl(-). NKCC1 activity is enhanced in the presence of an inward Cl(-) gradient. The results further indicate that the presence of functional CFTR enhances the expression of NKCC1. We speculate that CFTR regulates this process in a Cl(-)-dependent manner.</p>","PeriodicalId":7590,"journal":{"name":"American Journal of Physiology","volume":"277 6","pages":"C1100-10"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1152/ajpcell.1999.277.6.C1100","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21458678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}